It was observed that SETD2 loss triggered a switch from glycolysis to OXPHS in ccRCC cells (46), while tumors with high CuAGS-13 score exhibited higher frequencies of SETD2 mutations, which might provide potential explanation. This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.